After activist investor Quentin Koffey’s Politan Capital Management won a proxy battle at med tech company Masimo, the company’s new…
Apple wins $250 US jury verdict in patent case over Masimo smartwatches…
Masimo smartwatches infringe Apple patents, US jury says…
The company seems to be effecting a smooth transition in its leadership.…
Masimo (MASI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…
Masimo gains as activist Politan wins two board seats…
Activist investor Politan won the two board seats it was seeking at Masimo, defeating founder Joe Kiani and another director…
Shares of Masimo have risen since the news of a court ruling against Politan. The ruling is likely to favor…
Masimo has partnered with Google and Qualcomm to develop a reference platform to help bring more smartwatches to market with…
MASI Collaborates with Qualcomm to develop a reference platform for Wear OS smartwatches, combining biosensing tech and Snapdragon chips to…
…
Court documents unsealed on Friday show Masimo CEO Joe Kiani shared material non-public information with an investor in March just…
Masimo (MASI) receives unsolicited requests from multiple entities for acquiring its consumer business. The company already received a non-binding term…
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Strength in Healthcare revenues drive Masimos (MASI) second-quarter results.…
Masimo (MASI) sues Politan to correct material misstatements in an ongoing proxy battle, rescheduling its annual meeting. Politan denies allegations…
ISS recommends Masimo investors elect activist Politan candidates to board…
Proxy advisor Institutional Shareholder Services said boardroom change at medical technology company Masimo was "absolutely necessary."…
Masimo (MASI) gets an acquisition offer for its consumer business from an undisclosed entity. The deal is likely to close…
…
Masimo announces preliminary Q2 revenue above consensus estimates…
Masimo defends board nominee against activist investor Politan…
Masimo (MASI) collaborates with Cleveland Clinic to boost patient care by combining its Hospital Automation platform with the latters central…
A month ahead of Masimos annual meeting, activist investor Politan is laying out its case to shareholders to assume board…
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
Masimo offered to settle with a dissident director who is planning a second proxy fight.…
Masimo activist Quentin Koffey says hell pursue litigation if the health-tech company doesnt provide information on a proposed spinout of…
Masimo (MASI) is evaluating a proposed separation of its consumer audio and consumer health product business in a bid to…
Masimo (MASI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…
During the Investing Clubs Morning Meeting, Jim Cramer weighed in on the market-moving headlines around Boeing, Intel, Tesla and more…
Politan Capital Management is seeking two more seats on the board of Masimo Corp., marking its second proxy battle at…
Quentin Koffeys Politan Capital waged a successful proxy fight at Masimo last year, and it is now seeking two more…
These are the stocks posting the largest moves in premarket trading.…
Politan nominates two for Masimo board amid governance concerns…
Wells Fargo raises Masimo stock rating to Overweight, targets $160…
The company, which makes equipment such as a pulse oximeter, also sells baby monitors and smart watches under its brand.…
Masimo weighs spinoff of consumer business to unlock growth in healthcare unit…
NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Masimo stock climbs as Q4 earnings and revenue come ahead of expectations…
Masimo (MASI) collaborates with UCHealth to boost patient care by combining its latest virtual care technologies with UCHealths clinical expertise…
Apple will begin selling versions of its Series 9 and Ultra 2 watches without a blood oxygen feature in the…
Masimo (MASI) rides on the continuation of the import ban on certain models of Apple watches using disputed blood oxygen…
The patent dispute between Apple and Masimo will prevent the Apple Watch Series 9 from being sold in the U.S.…
Masimo stock pops as appeals court reinstates Apple Watch sales ban…
Nach der Niederlage im Patentstreit mit der Firma Masimo und einem US-Importstopp reagiert Apple. Der iPhone-Konzern deaktiviert in seinen neuen…
…
Masimo stock pops as preliminary Q4 results, guidance beat estimates…
Masimo shares slide on uncertain Apple Watch royalties - Needham & Company…
Apple (AAPL) wins a temporary reprieve in the patent battle over its smartwatches, pausing an import ban amid a legal…